Editorial: A Is for Amyloid.
作者信息
Selkoe D J
机构信息
D.J. Selkoe, Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA,
出版信息
J Prev Alzheimers Dis. 2020;7(3):140-141. doi: 10.14283/jpad.2020.27.
Abstract
摘要
相似文献
1
Editorial: A Is for Amyloid.社论：A代表淀粉样蛋白。
J Prev Alzheimers Dis. 2020;7(3):140-141. doi: 10.14283/jpad.2020.27.
2
Antibody drugs for Alzheimer's show glimmers of promise.用于治疗阿尔茨海默病的抗体药物展现出了些许希望。
Nature. 2015 Jul 30;523(7562):509-10. doi: 10.1038/nature.2015.18031.
3
Fluid Biomarker Changes After Amyloid-β-Targeting Drugs.
JAMA Neurol. 2024 Jun 1;81(6):579-581. doi: 10.1001/jamaneurol.2024.1103.
4
Revisiting FDA Approval of Aducanumab.重新审视阿杜卡努单抗的美国食品药品监督管理局批准情况。
N Engl J Med. 2021 Aug 26;385(9):769-771. doi: 10.1056/NEJMp2110468. Epub 2021 Jul 28.
5
Alzheimer disease: Anti-Aβ antibody treatment shows promise in Alzheimer disease.阿尔茨海默病：抗淀粉样前体蛋白抗体治疗在阿尔茨海默病中显示出前景。
Nat Rev Neurol. 2016 Oct;12(10):554-5. doi: 10.1038/nrneurol.2016.144. Epub 2016 Sep 16.
6
The search for Alzheimer disease therapeutics - same targets, better trials?阿尔茨海默病治疗方法的探索——相同靶点，更好的试验？
Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.
7
Structural aspects of Alzheimer's disease immunotherapy targeted against amyloid-beta peptide.针对淀粉样β肽的阿尔茨海默病免疫疗法的结构方面
Bratisl Lek Listy. 2018;119(4):201-204. doi: 10.4149/BLL_2018_037.
8
Alzheimer's drugs take a new tack.阿尔茨海默病药物有了新策略。
Nature. 2012 Sep 6;489(7414):13-4. doi: 10.1038/489013a.
9
Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease.阿杜卡努单抗治疗可改善阿尔茨海默病小鼠模型中的钙超载。
J Neurosci. 2017 Apr 26;37(17):4430-4432. doi: 10.1523/JNEUROSCI.0420-17.2017.
10
Amyloid Cascade into Clarity.淀粉样蛋白级联进入清晰状态。
Immunity. 2016 Oct 18;45(4):717-718. doi: 10.1016/j.immuni.2016.10.006.
引用本文的文献
1
The Single Toxin Origin of Alzheimer's Disease and Other Neurodegenerative Disorders Enables Targeted Approach to Treatment and Prevention.阿尔茨海默病及其他神经退行性疾病的单毒素起源为治疗和预防提供了靶向方法。
Int J Mol Sci. 2024 Feb 27;25(5):2727. doi: 10.3390/ijms25052727.
2
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses.阿尔茨海默病之谜：深入探究发病机制假说。
Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608.
3
Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey.Aβ前体蛋白转基因恒河猴的脑Aβ沉积
Aging Brain. 2022;2. doi: 10.1016/j.nbas.2022.100044. Epub 2022 Jun 17.
4
Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer's Disease.不同血液Aβ清除系统诱发Aβ流入血液：一种治疗阿尔茨海默病的潜在疗法。
Neuropsychiatr Dis Treat. 2021 Jul 13;17:2291-2308. doi: 10.2147/NDT.S317104. eCollection 2021.
5
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression.神经毒性可溶性淀粉样寡聚体驱动阿尔茨海默病的发病机制，代表了一种经过临床验证的可减缓疾病进展的目标。
Int J Mol Sci. 2021 Jun 14;22(12):6355. doi: 10.3390/ijms22126355.
6
Building clinically relevant outcomes across the Alzheimer's disease spectrum.构建贯穿阿尔茨海默病谱系的临床相关结果。
Alzheimers Dement (N Y). 2021 Jun 26;7(1):e12181. doi: 10.1002/trc2.12181. eCollection 2021.
7
Aβ Plaques.β淀粉样蛋白斑块
Free Neuropathol. 2020;1:31. doi: 10.17879/freeneuropathology-2020-3025. Epub 2020 Oct 30.
8
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer's Disease.接种β-淀粉样蛋白疫苗作为预防阿尔茨海默病的一种策略。
Biology (Basel). 2020 Nov 27;9(12):425. doi: 10.3390/biology9120425.
9
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.阿杜卡奴单抗、根特纳单抗、BAN2401 和 ALZ-801——用于治疗阿尔茨海默病的首批靶向淀粉样蛋白药物，具有近期获批的潜力。
Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.
本文引用的文献
1
The Future of Anti-Amyloid Trials.抗淀粉样蛋白治疗临床试验的未来。
J Prev Alzheimers Dis. 2020;7(3):146-151. doi: 10.14283/jpad.2020.24.
2
An in vitro paradigm to assess potential anti-Aβ antibodies for Alzheimer's disease.评估阿尔茨海默病潜在抗 Aβ 抗体的体外研究模型。
Nat Commun. 2018 Jul 11;9(1):2676. doi: 10.1038/s41467-018-05068-w.
3
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.阿尔茨海默病与高病理对照中的淀粉样β寡聚化。
Ann Neurol. 2013 Jan;73(1):104-19. doi: 10.1002/ana.23748. Epub 2012 Dec 7.
4
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.直接从阿尔茨海默病患者大脑中分离出的β-淀粉样蛋白二聚体损害突触可塑性和记忆。
Nat Med. 2008 Aug;14(8):837-42. doi: 10.1038/nm1782. Epub 2008 Jun 22.
Zotero 插件